<DOC>
	<DOCNO>NCT01945216</DOCNO>
	<brief_summary>The purpose study determine safety efficacy long-term treatment alogliptin ( Nesina ) patient type 2 diabetes mellitus respond inadequately diet therapy exercise therapy alone , combination diet therapy , exercise therapy , α-glucosidase inhibitor . In addition , examine safety efficacy alogliptin patient renal impairment , information appropriate dosage alogliptin accord severity impaired renal function collect .</brief_summary>
	<brief_title>Alogliptin Tablets Special Drug Use Surveillance `` Type 2 Diabetes Mellitus : Monotherapy/Combination Therapy With α-GI ''</brief_title>
	<detailed_description>A special drug use surveillance plan examine safety efficacy long-term use alogliptin patient type 2 diabetes mellitus daily clinical use condition . Participants surveillance patient type 2 diabetes mellitus fail respond adequately diet therapy exercise therapy alone combination diet therapy , exercise therapy , α-glucosidase inhibitor . The planned sample size 3,000 subject . The usual adult dosage oral use 1 alogliptin tablet ( 25 mg ) daily .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Alogliptin</mesh_term>
	<criteria>Patients type 2 diabetes mellitus adequately respond one follow therapy : 1 . Diet therapy exercise therapy alone 2 . In addition diet therapy exercise therapy , use αglucosidase inhibitor Patients contraindicate Nesina 1 . Patients severe ketosis , diabetic coma precoma , type 1 diabetes mellitus ( patient require prompt adjustment hyperglycemia fluid infusion insulin , hence use Nesina appropriate . ) 2 . Patients severe infection , pre postoperative patient , patient serious traumatic injury ( blood glucose control insulin injection desirable patient , hence use Nesina appropriate . ) 3 . Patients history hypersensitivity ingredient Nesina</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>